Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Paris  >  Genomic Vision    GV   FR0011799907

GENOMIC VISION

(GV)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Euronext Paris
11/19/2020 11/20/2020 11/23/2020 11/24/2020 11/25/2020 Date
1.012(c) 0.94(c) 0.93(c) 0.864(c) 0.872 Last
22 146 433 11 826 147 4 629 150 5 319 485 5 527 947 Volume
+15.00% -7.11% -1.06% -7.10% +0.93% Change
More quotes
Financials
Sales 2020 9,40 M 11,2 M 11,2 M
Net income 2020 -3,10 M -3,69 M -3,69 M
Net Debt 2020 6,90 M 8,22 M 8,22 M
P/E ratio 2020 -4,59x
Yield 2020 -
Sales 2021
Net income 2021
Net Debt 2021
P/E ratio 2021
Yield 2021
Capitalization 41,1 M 48,9 M 48,9 M
EV / Sales 2020 5,10x
EV / Sales 2021
Nbr of Employees 26
Free-Float 98,3%
More Financials
Company
Genomic Vision specializes in developing genetic diseases diagnosis tests and cancer genomic analysis. The group uses molecular combing technology which allows direct visualization of DNA individual molecules in order to detect the quantitative and qualitative changes of the genome and determine their role in targeted pathology. Net sales in 2019 break down by source of income as follows: - sales of equipments and... 
More about the company
All news about GENOMIC VISION
11/24GENOMIC VISION : As Part of the Financing Line Concluded With Winance, Genomic V..
BU
11/12GENOMIC VISION : Financial Information for the Third Quarter of 2020
BU
10/13GENOMIC VISION : Signs a Distribution Agreement for Covid-19 Rapid Diagnostic Te..
BU
09/29GENOMIC VISION :  First-half 2020 Results
BU
09/29GENOMIC VISION : Half-year results
CO
09/22GENOMIC VISION : Convening of Another Extraordinary General Meeting on October 3..
BU
08/10GENOMIC VISION : Announces the Approval by its General Meeting of all the Resolu..
BU
08/10GENOMIC VISION : Proxy Statments
CO
07/24GENOMIC VISION : Convening of a New Combined Shareholders' Meeting on August 10,..
BU
07/20GENOMIC VISION : Financial Information for the First Half of 2020
BU
07/20GENOMIC VISION : 2nd quarter earnings
CO
06/15GENOMIC VISION :  Implementation of a Financing Line via the Reserved Issuance o..
BU
05/29GENOMIC VISION : Financial Information for the First Quarter of 2020
BU
05/21GENOMIC VISION :  2019 Annual Results
BU
05/18GENOMIC VISION : As Part of the Financing Program Set up with Winance in 2019, G..
BU
More news
News in other languages on GENOMIC VISION
11/24Les valeurs à suivre aujourd'hui à la Bourse de Paris Mardi 24 novembre 2020
11/24GENOMIC VISION : émet sa première OCABSA pour 0,8 million d'euros
11/24EN DIRECT DES MARCHES : Total, JCDecaux, Neoen, Quadient, Tesla, Novartis, Gener..
11/24GENOMIC VISION : Dans le cadre du programme de financement conclu avec Winance, ..
11/13La différence entre un vaccin et une baguette magique
More news
Chart GENOMIC VISION
Duration : Period :
Genomic Vision Technical Analysis Chart | GV | FR0011799907 | MarketScreener
Technical analysis trends GENOMIC VISION
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
 
Mean consensus SELL
Number of Analysts 1
Average target price 0,15 €
Last Close Price 0,87 €
Spread / Highest target -82,8%
Spread / Average Target -82,8%
Spread / Lowest Target -82,8%
EPS Revisions
Managers
NameTitle
Dominique Remy-Renou Chairman-Executive Board
Elisabeth Ourliac Chairman-Supervisory Board
Stéphane Altaba Chief Operating Officer
Pierre Schwich Chief Financial & Administrative Officer
Aaron Bensimon Chief Scientific Officer
Sector and Competitors
1st jan.Capitalization (M$)
GENOMIC VISION154.87%48
LONZA GROUP AG56.17%44 950
MODERNA, INC.403.89%39 001
CELLTRION, INC.82.32%36 284
IQVIA HOLDINGS INC.11.32%32 977
SEAGEN INC.44.80%29 684